Public Company News

Trinasolar Releases Sustainability Report for 2023, Detailing its Commitment, Action and Achievements Towards a More Sustainable World

CHANGZHOU, China, June 3, 2024 /PRNewswire/ -- Trina Solar Co., Ltd. (688599. SH), one of the world's leaders in smart PV and energy storage solutions, recently released its2023 Sustainability Report ...

2024-06-03 17:43 3798

BRI Receives Analysts Buy Recommendation as MSMEs Financing Strategy Drives Growth

JAKARTA, Indonesia, June 3, 2024 /PRNewswire/ -- PT. Bank Rakyat Indonesia (Persero) Tbk (IDX: BBRI)remains Indonesia's leading MSME (Micro, Small and Medium Enterprise) financier, with its credit portfolio growing toIDR 1,308.65 trillion by March 2024, up 10.89% year-on-year. Over 83% of this, o...

2024-06-03 17:16 5977

Primax's 40th Anniversary Virtual Expo: Unveiling AI Innovations for a Smarter Future

Aligned with COMPUTEX 2024, Primax Showcases 3 Senses in one Integration Solutions TAIPEI, June 3, 2024 /PRNewswire/ -- Primax Electronics Ltd., a leader in 3 senses in 1 (interface, visual, and audio) integrated solutions, announces its 40th Anniversary Virtual Expo startingJune 4th. Coinciding...

2024-06-03 15:00 4340

Ericsson announces conclusion of Monitorship

* Ericsson's Monitorship and Plea Agreement concluded on June 2 * Follows upon certification of Ericsson's anti-corruption compliance program by independent Monitor inMarch 2024 * Continuing to cooperate fully with DOJ and SEC investigations on historical conduct STOCKHOLM, June 3, 2024 /PRN...

2024-06-03 14:40 2592

Formosa Laboratories Completes the Acquisition of Synchem to Expand North American CDMO Footprint

TAOYUAN, June 3, 2024 /PRNewswire/ -- Formosa Laboratories, Inc., a leading API supplier and CDMO headquartered inTaiwan, has successfully completed its acquisition of SynChem, Inc., a contract research laboratory located in suburban Chicago. SynChem will now operate under the new name SynChem-For...

2024-06-03 13:01 2524

Upcoming Acer Swift Series Laptops to Feature Models with New AMD Ryzen AI 300 Series Processors

TAIPEI, June 3, 2024 /PRNewswire/ -- Acer announced that its Swift series of thin-and-light laptops will feature models with the new AMD Ryzen™ AI 300 Series laptop processors, beginning in Q3 2024. Stacked with more CPU and GPU cores made available in this class of AMD-powered PCs, and equipped ...

2024-06-03 12:35 2698

Supermicro Liquid-Cooled AI SuperClusters Will Power Large-Scale AI Data Center in Japan

Working with Datasection, KDDI, and Sharp, Supermicro Will Deploy Rack Scale Plug-and-Play Liquid-Cooled AI Solutions with Advanced NVIDIA GPUs at a New AI Data Center -- AI Data Centers with Green Computing Can be Free with a Bonus  SAN JOSE, Calif. and TAIPEI, June 3, 2024 /PRNewswire/ -- Compu...

2024-06-03 10:58 4487

Alphamab Oncology Presented Chinese Clinical Data of Anti-HER2 Bispecific ADC JSKN003 for the First Time at the 2024 ASCO Annual Meeting

* Results from the phase I part of JSKN003-102 was reported at this ASCO Annual Meeting. * JSKN003 exhibited a favorable tolerability and manageable safety profile in heavily pretreated patients with advanced/metastatic solid tumors and demonstrated encouraging antitumor activity during dose ...

2024-06-03 10:17 2984

Innovent Delivers Oral Presentation of Clinical Data of A Randomized Controlled Phase 1b Study Evaluating IBI310 (Anti-CTLA-4 Monoclonal Antibody) in Combination with Sintilimab as Neoadjuvant Treatment of Colon Cancer at 2024 ASCO Annual Meeting

SAN FRANCISCO and SUZHOU, China, June 3, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune, ophthalmology and ot...

2024-06-03 09:44 4313

Innovent Delivers Oral Presentations at the 2024 ASCO Annual Meeting on Clinical Data of First-in-Class anti-CLDN18.2/CD3 Bispecific Antibody (IBI389) for the Treatment of Advanced Pancreatic Cancer and Gastric Cancer

SAN FRANCISCO and SUZHOU, China, June 3, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune...

2024-06-03 09:35 4909

Keymed Biosciences Announces Long-term Efficacy and Safety Data from a Phase III Clinical Trial of Stapokibart for the Treatment of Moderate-to-severe Atopic Dermatitis

CHENGDU, China, June 2, 2024 /PRNewswire/ -- Keymed Biosciences Inc. (HKEX: 02162) today announced the long-term efficacy and safety data of a Phase III clinical trial of stapokibart injection in patients with moderate-to-severe atopic dermatitis (AD) has been released by way of oral presentation...

2024-06-03 09:14 2722

Telix Completes TLX250-CDx (Zircaix®) BLA Submission for Kidney Cancer Imaging

MELBOURNE, Australia, June 3, 2024 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has completed the submission of a Biologics License Application (BLA) tothe United States (U.S.) Food and Drug Administration (FDA) for its investigational radi...

2024-06-03 09:08 2739

Kerry Logistics Network Commended for Comprehensive Climate Disclosure at the HKQAA Hong Kong Green and Sustainability Contribution Awards 2024

HONG KONG, June 3, 2024 /PRNewswire/ -- Kerry Logistics Network Limited ('Kerry Logistics Network', 'KLN'; Stock Code 0636.HK) is delighted to be recognised once again by the Hong Kong Quality Assurance Agency ('HKQAA'), winning the Pioneering Award for Climate Disclosure Contribution for its not...

2024-06-03 08:07 3139

DB HiTek Advances Global Shutter and SPAD

* Expanding specialized image sensor business applied to machine vision, autonomous vehicles, robotics, and medical devices * Collaborating on product development with leading companies in the US, Japan , andChina by providing global leading-edge processes SEOUL, South Korea, June 3, 2024 /PRN...

2024-06-03 08:00 5078

Kerry Logistics Network Named Global Logistics Company of Excellence by Hong Kong Economic Journal Corporate Brand Awards of Excellence 2024

HONG KONG, June 3, 2024 /PRNewswire/ -- Kerry Logistics Network Limited ('Kerry Logistics Network', 'KLN'; Stock Code 0636.HK) has been named the Global Logistics Company of Excellence by the Hong Kong Economic Journal Corporate Brand Awards of Excellence (the 'Awards') 2024, for its excellent co...

2024-06-03 07:11 3888

Innovent Announces Taletrectinib(ROS1 Inhibitor)Updated Data from Pivotal Phase 2 TRUST-I Study of are Published in the JCO and Orally Presentedat 2024 ASCO Annual Meeting

SAN FRANCISCO and SUZHOU, China, June 2, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune,...

2024-06-02 13:19 5874

Jacobio Pharma Presents SHP2 Plus KRAS G12C Data at ASCO

BEIJING and SHANGHAI and CHICAGO, June 1, 2024 /PRNewswire/ -- Jacobio Pharma (1167.HK), a clinical-stage oncology company focusing on undruggable targets, presented updated data of a KRAS G12C inhibitor glecirasib (JAB-21822) in combination with aSHP2 inhibitor (JAB-3312) in frontline non-small ...

2024-06-02 08:25 5107

CStone Announces European Medicine Agency CHMP Recommends Approval of Cejemly® (sugemalimab, anti-PD-L1) as First-Line Treatment for NSCLC

* EMA CHMP recommendation is based on the results of a Phase 3 clinical trial (GEMSTONE-302) demonstrating significant progression-free survival (PFS) and overall survival (OS) benefits of sugemalimab in combination with chemotherapy as a first-line treatment for non-small cell lung cancer (NSC...

2024-06-02 08:24 5690

Innovent Presents at the 2024 ASCO Annual Meeting on Clinical Data of anti-CLDN18.2 ADC (IBI343) in Patients with Advanced Pancreatic Cancer or Biliary Tract Cancer

SAN FRANCISCO, U.S. and SUZHOU, China, June 2, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, cardiovascular and metabolic, autoi...

2024-06-02 08:00 7203

Innovent Announces Data from Pivotal Phase 2 TRUST-I Study of Taletrectinib(ROS1 Inhibitor) are Published in the JCO and Reported at 2024 ASCO Annual Meeting

SAN FRANCISCO, U.S. and SUZHOU, China, June 2, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, cardiovascular and metabolic, autoi...

2024-06-02 08:00 5488